Assessing RET/PTC in thyroid nodule fine-needle aspirates: The FISH point of view

Endocrine-Related Cancer

Volumn 20, Issue 4, 2013, Pages 527-536

  Caria, Paola ^a   Dettori, Tinuccia ^a   Frau, Daniela V ^a   Borghero, Angela ^a   Cappai, Antonello ^a   Riola, Alessia ^a   Lai, Maria L ^a   Boi, Francesco ^a   Calò, Piergiorgio ^a   Nicolosi, Angelo ^a   Mariotti, Stefano ^a   Vanni, Roberta ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

FISH; Molecular genetics; Papillary thyroid cancer; Pathogenesis; RET PTC

Indexed keywords

PROTEIN RET;

ARTICLE; CYTOLOGY; FINE NEEDLE ASPIRATION BIOPSY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE REARRANGEMENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYROID CARCINOMA; THYROID FOLLICLE CELL;

FISH; MOLECULAR GENETICS; PAPILLARY THYROID CANCER; PATHOGENESIS; RET/PTC;

BIOPSY, FINE-NEEDLE; CARCINOMA; GENE REARRANGEMENT; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; PROTO-ONCOGENE PROTEINS B-RAF; PROTO-ONCOGENE PROTEINS C-RET; THYROID NEOPLASMS; THYROID NODULE;

EID: 84882769105     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1530/ERC-13-0157     Document Type: Article

References (35)

1. Adeniran AJ, Zhu Z, Gandhi M, Steward DL, Fidler JP, Giordano TJ, Biddinger PW & Nikiforov YE 2006 Correlation between genetic alterations and microscopic features, clinical manifestations, and prognostic characteristics of thyroid papillary carcinomas. American Journal of Surgical Pathology 30 216-222. (doi:10.1097/01.pas.0000176432.73455.1b)
2. Ali SZ, Fish SA, Lanman R, Randolph GW & Sosa JA 2013 Use of the Afirma® gene expression classifier for preoperative identification of benign thyroid nodules with indeterminate fine needle aspiration cytopathology. PLoS Currents. (doi:10.1371/currents.eogt.e557cbb5c7e4f66568ce582
3. Arora N, Scognamiglio T, Zhu B & Fahey TJ, III 2008 Do benign thyroid nodules have malignant potential? An evidence-based review World Journal of Surgery 32 1237-1246. (doi:10.1007/s00268-008-9484-1)
4. Boi F, Lai ML, Marziani B, Minerba L, Faa G & Mariotti S 2005 High prevalence of suspicious cytology in thyroid nodules associated with positive thyroid autoantibodies. European Journal of Endocrinology 153 637-642. (doi:10.1530/eje.1.02020)
5. Caria P & Vanni R 2010 Cytogenetic and molecular events in adenoma and well-differentiated thyroid follicular-cell neoplasia. Cancer Genetics and Cytogenetics 203 21-29. (doi:10.1016/j.cancergencyto.2010.08.025)
6. Caria P, Dettori T, Frau DV, Di Oto E, Morandi L, Parmeggiani A, Tallini G & Vanni R 2012 Simultaneous occurrence of PAX8-PPARg and RET-PTC3 rearrangements in a follicular variant of papillary thyroid carcinoma. American Journal of Surgical Pathology 36 1415-1420. (doi:10.1097/PAS.0b013e318264bdd6)
7. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M et al. 2009 Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 19 1167-1214. (doi:10.1089/thy.2009.0110)
8. Drieschner N, Rippe V, Laabs A, Dittberner L, Nimzyk R, Junker K, Rommel B, Kiefer Y, Belge G, Bullerdiek J et al. 2011 Interphase fluorescence in situ hybridization analysis detects a much higher rate of thyroid tumors with clonal cytogenetic deviations of the main cytogenetic subgroups than conventional cytogenetics. Cancer Genetics 204 366-374. (doi:10.1016/j.cancergen.2011.03.008)
9. Fagin JA 2004 Challenging dogma in thyroid cancer molecular genetics - role of RET/PTC and BRAF in tumor initiation. Journal of Clinical Endocrinology and Metabolism 89 4264-4266. (doi:10.1210/jc.2004-1426)
10. Ferraz C, Rehfeld C, Krogdahl A, Precht Jensen EM, Bösenberg E, Narz F, Hegedüs L, Paschke R & Eszlinger M 2012 Detection of PAX8/PPARG and RET/PTC rearrangements is feasible in routine air-dried fine needle aspiration smears. Thyroid 10 1025-1030. (doi:10.1089/thy.2011.0391)
11. Frau DV, Erdas E, Caria P, Ambu R, Dettori T, Faa G, Fletcher CD & Vanni R 2010 Deep fibrous histiocytoma with a clonal karyotypic alteration: molecular cytogenetic characterization of a t(16;17)(p13.3;q21.3). Cancer Genetics and Cytogenetics 202 17-21. (doi:10.1016/j.cancergencyto.2010.06.012)
12. Fusco A, Grieco M, Santoro M, Berlingieri MT, Pilotti S, Pierotti MA, Della Porta G & Vecchio G 1987 A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases. Nature 328 170-172. (doi:10.1038/328170a0)
13. Fusco A, Chiappetta G, Hui P, Garcia-Rostan G, Golden L, Kinder BK, Dillon DA, Giuliano A, Cirafici AM, Santoro M et al. 2002 Assessment of RET/PTC oncogene activation and clonality in thyroid nodules with incomplete morphological evidence of papillary carcinoma: a search for the early precursors of papillary cancer. American Journal of Pathology 160 2157-2167. (doi:10.1016/S0002-9440(10)61164-9)
14. Grieco M, Cerrato A, Santoro M, Grieco M, Cerrato A, Santoro M, Fusco A, Melillo RM & Vecchio G 1994 Cloning and characterization of H4 (D10S170), a gene involved in RET rearrangements in vivo. Oncogene 9 2531-2535.
15. Guerra A, Sapio MR, Marotta V, Campanile E, Moretti MI, Deandrea M, Motta M, Limone PP, Fenzi G, Rossi G et al. 2011 Prevalence of RET/PTC rearrangement in benign and malignant thyroid nodules and its clinical application. Endocrine Journal 58 31-38. (doi:10.1507/endocrj. K10E-260)
16. Guerra A, Sapio MR, Marotta V, Campanile E, Rossi S, Forno I, Fugazzola L, Budillon A, Moccia T, Fenzi G et al. 2012 The primary occurrence of BRAF(V600E) is a rare clonal event in papillary thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism 97 517-524. (doi:10.1210/jc.2011-0618)
17. Hieber L, Huber R, Bauer V, Schäffner Q, Braselmann H, Thomas G, Bogdanova T & Zitzelsberger H 2011 Chromosomal rearrangements in post-Chernobyl papillary thyroid carcinomas: evaluation by spectral karyotyping and automated interphase FISH. Journal of Biomedicine and Biotechnology 2011 693691. (doi:10.1155/2011/693691)
18. Hodak SP, Rosenthal DS & For The American Thyroid Association Clinical Affairs Committee 2013 Information for clinicians: commercially available molecular diagnosis testing in the evaluation of thyroid nodule FNA specimens. Thyroid 23 131-134. (doi:10.1089/thy.2012.0320)
19. Ishizaka Y, Kobayashi S, Ushijima T, Hirohashi S, Sugimura T & Nagao M 1991 Detection of retTPC/PTC transcripts in thyroid adenomas and adenomatous goiter by an RT-PCR method. Oncogene 6 1667-1672. (Pubitemid 21924271)
20. Kim H, Yoo SB, Choe JY, Paik JH, Xu X, Nitta H, Zhang W, Grogan TM, Lee CT, Jheon S et al. 2006 Detection of ALK gene rearrangement in non-small cell lung cancer: a comparison of fluorescence in situ hybridization and chromogenic in situ hybridization with correlation of ALK protein expression. Journal of Thoracic Oncology 6 1359-1366. (doi:10.1097/JTO.0b013e31821cfc73)
21. Marotta V, Guerra A, Sapio MR & Vitale M 2011 RET/PTC rearrangement in benign and malignant thyroid diseases: a clinical standpoint. European Journal of Endocrinology 165 499-507. (doi:10.1530/EJE-11-0499)
22. Mehta V, Nikiforov YE & Ferris RL 2012 Use of molecular biomarkers in FNA specimens to personalize treatment for thyroid surgery. Head & Neck [in press]. (doi:10.1002/hed.23140)
23. Nakazawa T, Murata S, Kondo T, Niu D, Mochizuki K, Kawasaki T, Yamane T, Nakamura N & Katoh R 2009 RET/PTC rearrangements arising from a small population of papillary thyroid carcinoma cells, possible candidate for passenger mutation. Virchows Archiv 455 35-41. (doi:10.1007/s00428-009-0789-8)
24. Nikiforov YE 2006 RET/PTC rearrangement - a link between Hashimoto's thyroiditis and thyroid cancer.or not. Journal of Clinical Endocrinology and Metabolism 91 2040-2042. (doi:10.1210/jc.2006-0791)
25. Nikiforov YE & Nikiforova MN 2011 Molecular genetics and diagnosis of thyroid cancer. Nature Reviews. Endocrinology 7 569-580. (doi:10.1038/nrendo. 2011.142)
26. Nikiforov YE, Rowland JM, Bove KE, Monforte-Munoz H & Fagin JA 1997 Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary carcinomas in children. Cancer Research 57 1690-1694. (Pubitemid 27199660)
27. Petersen BL, Sørensen MC, Pedersen S & Rasmussen M 2004 Fluorescence in situ hybridization on formalin-fixed and paraffin-embedded tissue: optimizing the method. Applied Immunohistochemistry & Molecular Morphology 12 259-265. (doi:10.1097/00129039-200409000-00013)
28. Rhoden KJ, Unger K, Salvatore G, Yilmaz Y, Vovk V, Chiappetta G, Qumsiyeh MB, Rothstein JL, Fusco A, Santoro M et al. 2006 RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma. Journal of Clinical Endocrinology and Metabolism 91 2414-2423. (doi:10.1210/jc.2006-0240)
29. Santoro M, Chiappetta G, Cerrato A, Salvatore D, Zhang L, Manzo G, Picone A, Portella G, Santelli G, Vecchio G et al. 1996 Development of thyroid papillary carcinomas secondary to tissue-specific expression of the RET/PTC1 oncogene in transgenic mice. Oncogene 12 1821-1826. (Pubitemid 26146307)
30. Santoro M, Melillo RM & Fusco A 2006 RET/PTC activation in papillary thyroid carcinoma. European Journal of Endocrinology 155 645-653. (doi:10.1530/eje.1.02289)
31. Unger K, Zitzelsberger H, Salvatore G, Santoro M, Bogdanova T, Braselmann H, Kastner P, Zurnadzhy L, Tronko N, Hutzler P et al. 2004 Heterogeneity in the distribution of RET/PTC rearrangements within individual post-Chernobyl papillary thyroid carcinomas. Journal of Clinical Endocrinology and Metabolism 89 4272-4279. (doi:10.1210/jc.2003-031870)
32. Wiktor AE, Van Dyke DL, Stupca PJ, Ketterling RP, Thorland EC, Shearer BM, Fink SR, Stockero KJ, Majorowicz JR & Dewald GW 2006 Preclinical validation of fluorescence in situ hybridization assays for clinical practice. Genetics in Medicine 8 16-23. (doi:10.1097/01.gim.0000195645.00446.61)
33. Wolff DJ, Bagg A, Cooley LD, Dewald GW, Hirsch BA, Jacky PB, Rao KW & Rao PN 2007 Guidance for fluorescence in situ hybridization testing in hematologic disorders. Association for Molecular Pathology Clinical Practice Committee; American College of Medical Genetics Laboratory Quality Assurance Committee. Journal of Molecular Diagnostics 9 134-143. (doi:10.2353/jmoldx.2007. 060128)
34. Xing M 2007 BRAF mutation in papillary thyroid cancer: pathogenetic role, molecular bases, and clinical implications. Endocrine Reviews 28 742-762. (doi:10.1210/er.2007-0007)
35. Zhu Z, Ciampi R, Nikiforova MN, Gandhi M & Nikiforov YE 2006 Prevalence of RET/PTC rearrangements in thyroid papillary carcinomas: effects of the detection methods and genetic heterogeneity. Journal of Clinical Endocrinology and Metabolism 91 3603-3610. (doi:10.1210/jc.2006-1006)